ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Samsung Bioepis secures positive CHMP opinion for Aybintio pharmaceutical-technology
June 28, 2020Korean biopharmaceutical firm Samsung Bioepis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for Aybintio, a biosimilar to Avastin (bevacizumab).
Pharma Sources Insight January 2025
